{"organizations": [], "uuid": "142e81fcee7d7c910d0b6f05b0a3be2320a0aecf", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180308.html", "section_title": "Archive News &amp; Video for Thursday, 08 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/aspen-pharmacare-results/therapeutic-brands-help-lift-aspen-pharmacares-h1-profit-idUSL5N1QP404", "country": "US", "domain_rank": 408, "title": "Therapeutic brands help lift Aspen Pharmacare's H1 profit", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-08T13:26:00.000+02:00", "replies_count": 0, "uuid": "142e81fcee7d7c910d0b6f05b0a3be2320a0aecf"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/aspen-pharmacare-results/therapeutic-brands-help-lift-aspen-pharmacares-h1-profit-idUSL5N1QP404", "ord_in_thread": 0, "title": "Therapeutic brands help lift Aspen Pharmacare's H1 profit", "locations": [], "entities": {"persons": [{"name": "biju dwarakanath", "sentiment": "none"}, {"name": "nqobile dludla", "sentiment": "none"}], "locations": [{"name": "johannesburg", "sentiment": "none"}, {"name": "south africa", "sentiment": "none"}, {"name": "aspen", "sentiment": "none"}], "organizations": [{"name": "aspen pharmacare", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "thomson reuters trust principles", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "JOHANNESBURG, March 8 (Reuters) - South Africaâ€™s Aspen Pharmacare said on Thursday first-half earnings rose 26 percent, buoyed by a strong result from therapeutic focused brands.\nAspen, with presence in 50 countries spanning six continents, said normalised headline earnings per share (HEPS) for the six-months ended Dec.31, rose to 872 cents from 692 cents.\nHEPS is the main profit gauge in South Africa, which strips out certain one-off items.\nGroup revenue grew 11 percent to 21.9 billion rand ($1.85 billion) from 19.8 billion rand.\n$1 = 11.8355 rand Reporting by Nqobile Dludla; Editing by Biju Dwarakanath\nOur Standards: The Thomson Reuters Trust Principles.", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-08T13:26:00.000+02:00", "crawled": "2018-03-09T14:18:20.012+02:00", "highlightTitle": ""}